文献速递其他结缔组织病

唾液腺超声纳入ACR/EULAR原发性干燥综合征分类标准的影响

Incorporation of Salivary Gland Ultrasonography Into the American College of Rheumatology/European League Against Rheumatism Criteria for Primary Sjögren's Syndrome.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2020-01-01

在243例连续患者中评估唾液腺超声(SGUS)加入或替换ACR/EULAR原发性干燥综合征分类标准条目对诊断效能的影响,以临床诊断为金标准。SGUS最佳截断值为≥1.5,最佳权重为1分;加入SGUS后标准效能保持高位,但以SGUS替换唾液腺活检或抗SSA抗体时敏感性明显下降。

要点

  • SGUS阳性最佳截断值为≥1.5,最佳权重为1分,ACR/EULAR达标阈值仍为≥4分。
  • 加入SGUS后,唇腺活检亚组AUC 0.966、敏感性97.3%、特异性90.2%。
  • 以SGUS替换唾液腺活检或抗SSA抗体时敏感性明显下降,替换眼染色评分、Schirmer试验或非刺激全唾液流率时效能相当。

核心结论

  • 纳入SGUS后ACR/EULAR分类标准的有效性仍然很高,SGUS为临床评估标准达标提供了更多检查选择。

研究设计与样本

  • 连续纳入243例具有全部ACR/EULAR条目完整数据并接受SGUS检查的患者,以主治医师临床诊断为金标准。
  • 对接受唇腺活检(n=124)或腮腺活检(n=198)的患者分别进行分析。
  • 采用1个腮腺和1个下颌下腺低回声区平均评分(范围0-3),评估加入SGUS或以其替换现有条目后的标准效能。

主要发现

  • ROC分析显示SGUS最佳截断值为≥1.5,SGUS阳性的最佳权重为1分,ACR/EULAR达标阈值仍为≥4分。
  • 唇腺活检亚组(n=124)原标准AUC 0.965、敏感性95.9%、特异性92.2%;加入SGUS后AUC 0.966、敏感性97.3%、特异性90.2%。
  • 腮腺活检亚组(n=198)结果相似。
  • 以SGUS替换唾液腺活检或抗SSA抗体时标准敏感性明显下降,替换眼染色评分、Schirmer试验或非刺激全唾液流率时效能相当。

关键数值与推荐

  • SGUS最佳截断值≥1.5,SGUS阳性权重1分,ACR/EULAR达标阈值≥4分。
  • 唇腺活检亚组原标准AUC 0.965、敏感性95.9%、特异性92.2%;加入SGUS后AUC 0.966、敏感性97.3%、特异性90.2%。

临床怎么用

  • 临床可在ACR/EULAR标准评估中纳入SGUS(截断值≥1.5,权重1分)以辅助判断达标。
  • 不宜以SGUS替换唾液腺活检或抗SSA抗体,因敏感性明显下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether the addition of salivary gland ultrasonography (SGUS) or replacement of current criteria items by SGUS influences the performance of the American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) criteria for primary Sjögren's syndrome. METHODS: Included were consecutive patients with complete data on all ACR/EULAR items (n = 243) who underwent SGUS in our primary Sjögren's syndrome expertise center. Clinical diagnosis by the treating physician was used as the gold standard. Separate analyses were performed for patients who underwent labial or parotid gland biopsies. The average score for hypoechogenic areas in 1 parotid and 1 submandibular gland was determined (range 0-3). Next, performance of the ACR/EULAR criteria was evaluated after addition of SGUS or replacement of current items by SGUS. RESULTS: Receiver operating characteristic analysis showed an optimal cutoff value of ≥1.5 for SGUS. The optimal weight for SGUS positivity was 1. Cutoff for ACR/EULAR fulfilment remained ≥4. In patients who underwent a labial gland biopsy (n = 124), the original criteria showed an area under the curve (AUC) of 0.965, sensitivity of 95.9%, and specificity of 92.2%. After the addition of SGUS, the AUC was 0.966, with a sensitivity of 97.3% and specificity of 90.2%. In patients who underwent a parotid gland biopsy (n = 198), similar results were found. Sensitivity of the criteria decreased substantially when SGUS replaced salivary gland biopsy or anti-SSA antibodies, while performance remained equal when SGUS replaced the ocular staining score, Schirmer's test, or unstimulated whole saliva flow. CONCLUSION: Validity of the ACR/EULAR criteria remains high after incorporation of SGUS. With SGUS, clinicians are offered a larger array of tests to evaluate fulfillment of the ACR/EULAR criteria.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. van Nimwegen JF, Mossel E, Delli K, et al. Incorporation of Salivary Gland Ultrasonography Into the American College of Rheumatology/European League Against Rheumatism Criteria for Primary Sjögren's Syndrome. Arthritis Care Res (Hoboken). 2020. PMID: 31254454. doi:10.1002/acr.24017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。